Abstract
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Rectal Cancer address diagnosis, staging, surgical management, perioperative treatment, management of recurrent and metastatic disease, disease surveillance, and survivorship in patients with rectal cancer. This portion of the guidelines focuses on the management of localized disease, which involves careful patient selection for curative-intent treatment options that sequence multimodality therapy usually comprised of chemotherapy, radiation, and surgical resection.
Copyright © 2018 by the National Comprehensive Cancer Network.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / standards
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biopsy
-
Chemoradiotherapy / methods
-
Chemoradiotherapy / standards
-
Disease-Free Survival
-
Humans
-
Incidence
-
Induction Chemotherapy / methods
-
Medical Oncology / standards*
-
Neoadjuvant Therapy / methods
-
Neoadjuvant Therapy / standards
-
Neoplasm Recurrence, Local / diagnosis
-
Neoplasm Recurrence, Local / epidemiology
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / therapy*
-
Neoplasm Staging
-
Patient Selection
-
Proctectomy / methods
-
Proctectomy / standards
-
Randomized Controlled Trials as Topic
-
Rectal Neoplasms / diagnosis
-
Rectal Neoplasms / epidemiology
-
Rectal Neoplasms / pathology
-
Rectal Neoplasms / therapy*
-
Rectum / pathology
-
Rectum / surgery
-
Societies, Medical / standards*
-
United States / epidemiology
-
Watchful Waiting / methods
-
Watchful Waiting / standards